KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) Stock Surge – Street Says Beware
KaloBios Pharmaceuticals Inc shot up close by almost 50% in Friday pre-market trading. CEO Martin Shkreli said on Twitter that he would not lend any more of his stock to short sellers. Popular blogger The Fly cited Markit data to indicate that 49% of KaloBios stock is being held in short positions. This means that…